Skip to Main Content

Paper Details

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
39
2016
Cell Lung Cancer, PATIENTS, Patients, cisplatin, esophageal perforation, esophagitis, non-small cell lung cancer, patients, pneumonitis, vinorelbine
Author NameAffiliation
Angela BakerClatterbridge Cancer Centre
Val??rie LaurencePoole Hospital
  • 1 - 2

Datasets

Release 1.2